Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389)

Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389) Publisher

Khonsari F¹ ; Heydari M² ; Dinarvand R³ ; Sharifzadeh M⁴ ; Atyabi F^{1, 2, 3}

Show Affiliations

1. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3. Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: BioImpacts Published:2022

Abstract

This corrects the article Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers published in 2022: Volume 12, Issue 1, Pages 21-32 (doi: 10.34172/ bi.2021.23389). The original version of this article contained an error in Fig. 3. The confocal images for cellular uptake of coumarin-6 loaded bare NLCs (B-NLC), and transferrin decorated NLCs (Tf-NLC) after 2 hours incubation was mixed up and two different resolutions of the same specimen mistakenly named and reported unintentionally. © 2022 The Author(s).

Style	Citing Format
MLA	Khonsari F, et al.. "Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389)." BioImpacts, vol. 12, no. 6, 2022, pp. 589-.
APA	Khonsari F, Heydari M, Dinarvand R, Sharifzadeh M, Atyabi F (2022). Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389). BioImpacts, 12(6), 589-.
Chicago	Khonsari F, Heydari M, Dinarvand R, Sharifzadeh M, Atyabi F. "Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389)." BioImpacts 12, no. 6 (2022): 589-.
Harvard	Khonsari F et al. (2022) 'Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389)', BioImpacts, 12(6), pp. 589-.
Vancouver	Khonsari F, Heydari M, Dinarvand R, Sharifzadeh M, Atyabi F. Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389). BioImpacts. 2022;12(6):589-.
BibTex	@article{ author = {Khonsari F and Heydari M and Dinarvand R and Sharifzadeh M and Atyabi F}, title = {Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389)}, journal = {BioImpacts}, volume = {12}, number = {6}, pages = {589-}, year = {2022} }
RIS	TY - JOUR AU - Khonsari F AU - Heydari M AU - Dinarvand R AU - Sharifzadeh M AU - Atyabi F TI - Correction: Brain Targeted Delivery of Rapamycin Using Transferrin Decorated Nanostructured Lipid Carriers (Bioimpacts (2022) 12:1 (21-32) Doi: 10.34172/Bi.2021.23389) JO - BioImpacts VL - 12 IS - 6 SP - 589 EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract